Monday, February 12, 2024 8:53:20 AM
Recent MGRX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 06:57:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 05:28:45 PM
- MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:24 PM
- MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies • GlobeNewswire Inc. • 06/04/2024 08:00:00 PM
- MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications • GlobeNewswire Inc. • 05/21/2024 12:30:00 PM
- MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration • GlobeNewswire Inc. • 05/16/2024 08:40:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/16/2024 05:59:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/16/2024 01:19:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:52:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2024 01:00:58 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/06/2024 09:32:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/06/2024 08:43:00 PM
- Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
- Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products • GlobeNewswire Inc. • 04/12/2024 12:45:00 PM
- MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth • GlobeNewswire Inc. • 02/20/2024 02:00:00 PM
- MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM